In a filing, CryoPort Inc revealed its Director Hariri Robert J unloaded Company’s shares for reported $43000.0 on Aug 22 ’25. In the deal valued at $8.60 per share,5,000 shares were sold. As a result of this transaction, Hariri Robert J now holds 26,275 shares worth roughly $0.27 million.
Then, STEFANOVICH ROBERT sold 9,300 shares, generating $80,618 in total proceeds. Upon selling the shares at $8.67, the Chief Financial Officer now owns 207,213 shares.
Before that, ROBERT S. STEFANOVICH bought 9,300 shares. CryoPort Inc shares valued at $80,618 were divested by the Officer at a price of $8.67 per share.
Leerink Partners upgraded its CryoPort Inc [CYRX] rating to an Outperform from a a Market perform in a research note published recently. A number of analysts have revised their coverage, including KeyBanc Capital Markets’s analysts, who increased its forecast for the stock in early August from “a Sector weight” to “an Overweight”. UBS revised its rating on March 24, 2025. It rated CYRX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of CYRX
On Friday, CryoPort Inc [NASDAQ:CYRX] saw its stock jump 16.95% to $10.35. Over the last five days, the stock has gained 19.10%. CryoPort Inc shares have risen nearly 19.38% since the year began. Nevertheless, the stocks have risen 33.03% over the past one year. While a 52-week high of $9.48 was reached on 09/05/25, a 52-week low of $4.58 was recorded on 03/04/25.
Levels Of Support And Resistance For CYRX Stock
The 24-hour chart illustrates a support level at 9.34, which if violated will result in even more drops to 8.32. On the upside, there is a resistance level at 10.88. A further resistance level may holdings at 11.40.
How much short interest is there in CryoPort Inc?
A steep rise in short interest was recorded in CryoPort Inc stocks on 2025-08-15, growing by 31887.0 shares to a total of 2.73 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 2.7 million shares. There was a rise of 1.17%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 19, 2024 when Guggenheim began covering the stock and recommended ‘”a Buy”‘ rating along with a $11 price target.
